Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: J Neuroophthalmol. 2019 Jun;39(2):191–199. doi: 10.1097/WNO.0000000000000760

Table 1.

ST266 Treatment Groups

Group Treatment Cohort ST266 treatment Placebo treatment
1 Control (non-EAE) mice - PBS daily, days 15-56
2 EAE mice - PBS daily, days 15-56
3 EAE mice - 0.5% HSA daily, days 15-56
4 EAE mice Once/day, days 15-30 PBS daily, days 31-56
5 EAE mice Twice/day, days 15-30 PBS twice daily, days 31-56
6 EAE mice Once/day, days 15-56 -
7 EAE mice Twice/day, days 15-56 -